Volltextdatei(en) vorhanden
DC ElementWertSprache
dc.contributor.advisorJücker, Manfred (Prof. Dr.)
dc.contributor.authorEwald, Florian
dc.date.accessioned2020-10-19T12:54:24Z-
dc.date.available2020-10-19T12:54:24Z-
dc.date.issued2012
dc.identifier.urihttps://ediss.sub.uni-hamburg.de/handle/ediss/5077-
dc.description.abstractBackground: Due to the frequent dysregulation of the PI3K/AKT/mTOR signaling pathway, mTOR represents a suitable therapeutic target in hepatocellular carcinoma (HCC). However, emerging data from clinical trials of HCC patients indicate that mTOR inhibition by RAD001 (Everolimus) alone has only moderate antitumor efficacy which may be due to the feedback activation of AKT after mTOR inhibition. In this study, we analyzed the effects of dual inhibition of mTOR and AKT on the proliferation of HCC cell lines. In addition, we measured the feedback activation of each of the AKT isoforms after mTOR inhibition in HCC cell lines and their enzymatic activity in primary samples from HCC patients. Methods: The activation status of specific AKT isoforms in human HCC samples and corresponding healthy liver tissue was analyzed using an AKT isoform specific in vitro kinase assay. AKT isoform activation after mTOR inhibition was analyzed in three HCC cell lines (Hep3B, HepG2 and Huh7), and the impact of AKT signaling on proliferation after mTOR inhibition was investigated using the novel AKT inhibitor MK-2206 and AKT isoform specific knockdown cells. Results: AKT isoforms become differentially activated during feedback activation following RAD001 treatment. The combination of mTOR inhibition and AKT isoform knockdown showed only a weak synergistic effect on proliferation of HCC cell lines. However, the combinatorial treatment with RAD001 and the pan AKT inhibitor MK-2206 resulted in a strong synergism, both in vitro and in vivo. Moreover, by analyzing primary HCC tissue samples we were able to demonstrate that a hotspot mutation (H1047R) of PI3KCA, the gene encoding the catalytic subunit of PI3K, was associated with increased in vitro kinase activity of all AKT isoforms in comparison to healthy liver tissue of the patient. Conclusion: Our results demonstrate that dual targeting of mTOR and AKT by use of RAD001 and the pan AKT inhibitor MK-2206 does effectively inhibit proliferation of HCC cell lines. These data suggest that combined treatment with RAD001 and MK-2206 may be a promising therapy approach in the treatment of hepatocellular carcinoma.en
dc.language.isodede
dc.publisherStaats- und Universitätsbibliothek Hamburg Carl von Ossietzky
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.subjectmTORen
dc.subjectAKTen
dc.subjectHCCen
dc.subject.ddc610 Medizin, Gesundheit
dc.titleCombined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cellsde
dc.title.alternativeKombinierte Inhibition von AKT und mTOR hemmt synergistisch das Wachstum von hepatozellulären Karzinom-Zellende
dc.typedoctoralThesis
dcterms.dateAccepted2013-06-25
dc.rights.ccNo license
dc.rights.rshttp://rightsstatements.org/vocab/InC/1.0/
dc.subject.bcl44.81 Onkologie
dc.type.casraiDissertation-
dc.type.dinidoctoralThesis-
dc.type.driverdoctoralThesis-
dc.type.statusinfo:eu-repo/semantics/publishedVersion
dc.type.thesisdoctoralThesis
tuhh.opus.id6367
tuhh.opus.datecreation2013-08-30
tuhh.type.opusDissertation-
thesis.grantor.departmentMedizin
thesis.grantor.placeHamburg
thesis.grantor.universityOrInstitutionUniversität Hamburg
dcterms.DCMITypeText-
tuhh.gvk.ppn76931600X
dc.identifier.urnurn:nbn:de:gbv:18-63675
item.advisorGNDJücker, Manfred (Prof. Dr.)-
item.grantfulltextopen-
item.languageiso639-1other-
item.fulltextWith Fulltext-
item.creatorOrcidEwald, Florian-
item.creatorGNDEwald, Florian-
Enthalten in den Sammlungen:Elektronische Dissertationen und Habilitationen
Dateien zu dieser Ressource:
Datei Beschreibung Prüfsumme GrößeFormat  
Dissertation.pdf9940d2408b1e1b6b6b10ccba92fc2f4f2.4 MBAdobe PDFÖffnen/Anzeigen
Zur Kurzanzeige

Diese Publikation steht in elektronischer Form im Internet bereit und kann gelesen werden. Über den freien Zugang hinaus wurden durch die Urheberin / den Urheber keine weiteren Rechte eingeräumt. Nutzungshandlungen (wie zum Beispiel der Download, das Bearbeiten, das Weiterverbreiten) sind daher nur im Rahmen der gesetzlichen Erlaubnisse des Urheberrechtsgesetzes (UrhG) erlaubt. Dies gilt für die Publikation sowie für ihre einzelnen Bestandteile, soweit nichts Anderes ausgewiesen ist.

Info

Seitenansichten

444
Letzte Woche
Letzten Monat
geprüft am 28.03.2024

Download(s)

198
Letzte Woche
Letzten Monat
geprüft am 28.03.2024
Werkzeuge

Google ScholarTM

Prüfe